The first in our series of “Quick Take” resources, this document provides an introduction to adeno-associated virus (AAV) virus vectors and their use in rare diseases. It outlines:
- What AAVs are
- Why AAVs are exciting in rare diseases
- Current and potential clinical targets for AAVs
- Current FDA-approved therapies using AAVs
- Clinical challenges associated with AAVs and potential solutions